These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

683 related articles for article (PubMed ID: 19667559)

  • 21. Use of quantitative cultures and reduced duration of antibiotic regimens for patients with ventilator-associated pneumonia to decrease resistance in the intensive care unit.
    Chastre J; Luyt CE; Combes A; Trouillet JL
    Clin Infect Dis; 2006 Sep; 43 Suppl 2():S75-81. PubMed ID: 16894519
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Prevention of ventilator associated pneumonia in an intensive care unit].
    Petersen IS; Bonde J
    Ugeskr Laeger; 2007 Dec; 169(49):4268-71. PubMed ID: 18208707
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hospital-acquired pneumonia and ventilator-associated pneumonia: recent advances in epidemiology and management.
    Barbier F; Andremont A; Wolff M; Bouadma L
    Curr Opin Pulm Med; 2013 May; 19(3):216-28. PubMed ID: 23524477
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A prospective study of hospital-acquired infections in burn patients at a tertiary care referral centre in North India.
    Taneja N; Emmanuel R; Chari PS; Sharma M
    Burns; 2004 Nov; 30(7):665-9. PubMed ID: 15475139
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is antibiotic cycling the answer to preventing the emergence of bacterial resistance in the intensive care unit?
    Kollef MH
    Clin Infect Dis; 2006 Sep; 43 Suppl 2():S82-8. PubMed ID: 16894520
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pneumonia observational incidence and treatment: a multidisciplinary process improvement study.
    Brozek J; McDonald E; Clarke F; Gosse C; Jaeschke R; Cook D
    Am J Crit Care; 2007 May; 16(3):214-9. PubMed ID: 17460312
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Advances in the management of pneumonia in the intensive care unit: review of current thinking.
    Rello J; Diaz E; Rodríguez A
    Clin Microbiol Infect; 2005 Oct; 11 Suppl 5():30-8. PubMed ID: 16138817
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effectiveness of programs to decrease antimicrobial resistance in the intensive care unit.
    Hall CS; Ost DE
    Semin Respir Infect; 2003 Jun; 18(2):112-21. PubMed ID: 12840792
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prediction of infection due to antibiotic-resistant bacteria by select risk factors for health care-associated pneumonia.
    Shorr AF; Zilberberg MD; Micek ST; Kollef MH
    Arch Intern Med; 2008 Nov; 168(20):2205-10. PubMed ID: 19001196
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Infectious diseases in the critically ill patients.
    Martin SJ; Yost RJ
    J Pharm Pract; 2011 Feb; 24(1):35-43. PubMed ID: 21507873
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Appropriate empiric antimicrobial therapy of nosocomial pneumonia: the role of the carbapenems.
    Kollef MH
    Respir Care; 2004 Dec; 49(12):1530-41. PubMed ID: 15571647
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Empiric de-escalation strategy of antibiotic treatment].
    Adukauskiene D; Vitkauskiene A
    Medicina (Kaunas); 2006; 42(9):703-8. PubMed ID: 17028467
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antimicrobial stewardship in the intensive care unit: a focus on potential pitfalls.
    Njoku JC; Hermsen ED
    J Pharm Pract; 2010 Feb; 23(1):50-60. PubMed ID: 21507793
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Antibiotic strategies in the treatment of infection in critically ill patients].
    Schierbeck J; Kolmos HJ
    Ugeskr Laeger; 2007 Feb; 169(8):699-702. PubMed ID: 17313920
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intensive care unit-acquired urinary tract infections in patients admitted with sepsis: etiology, risk factors, and patterns of antimicrobial resistance.
    Mojtahedzadeh M; Panahi Y; Fazeli MR; Najafi A; Pazouki M; Navehsi BM; Bazzaz A; Naghizadeh MM; Beiraghdar F
    Int J Infect Dis; 2008 May; 12(3):312-8. PubMed ID: 18032082
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neonatal nosocomial sepsis in a level-III NICU: evaluation of the causative agents and antimicrobial susceptibilities.
    Yalaz M; Cetin H; Akisu M; Aydemir S; Tunger A; Kültürsay N
    Turk J Pediatr; 2006; 48(1):13-8. PubMed ID: 16562780
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of the intensive care unit environment in the pathogenesis and prevention of ventilator-associated pneumonia.
    Crnich CJ; Safdar N; Maki DG
    Respir Care; 2005 Jun; 50(6):813-36; discussion 836-8. PubMed ID: 15913471
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of device associated infection rates in intensive care units of Pamukkale University Hospital.
    Turgut H; Sacar S; Okke D; Kavas ST; Asan A; Kutlu SS
    Infection; 2008 Jun; 36(3):262-5. PubMed ID: 18454338
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Resistance to antibiotics and multiresistant pathogens].
    Kerwat K; Kerwat M; Graf J; Wulf H
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2010 Apr; 45(4):242-3. PubMed ID: 20387180
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Successful prevention of ventilator-associated pneumonia in an intensive care setting.
    Marra AR; Cal RG; Silva CV; Caserta RA; Paes AT; Moura DF; dos Santos OF; Edmond MB; Durão MS
    Am J Infect Control; 2009 Oct; 37(8):619-25. PubMed ID: 19559503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.